Close Menu

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for Quanterix's Simoa SARS-CoV-2 N Protein Antigen Test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.